These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7326856)

  • 1. [Treatment of Cushing's disease with o, p'-DDD (author's transl)].
    Nakagawa K; Ito S; Ohara T; Kubo M; Horikawa H
    Horumon To Rinsho; 1981 Sep; 29(9):1135-9. PubMed ID: 7326856
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of Cushing's disease treated with o,p'-DDD].
    Kaneko K; Saito T; Fujioka T; Sugita Y; Takai K
    Horumon To Rinsho; 1982 Oct; 30(10):1071-6. PubMed ID: 7165981
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of Cushing's disease with o,p'-DDD.
    Cooper PR; Shucart WA
    N Engl J Med; 1979 Jul; 301(1):48-9. PubMed ID: 449914
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of o,p'-DDD on plasma ACTH concentration in Cushing's disease.
    Bruno OD; Hoschoian JC; Andrada JA
    Medicina (B Aires); 1979; 39(2):229-34. PubMed ID: 228150
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma level monitoring of mitotane (o,p'-DDD) and its metabolite (o,p'-DDE) during long-term treatment of Cushing's disease with low doses.
    Benecke R; Keller E; Vetter B; de Zeeuw RA
    Eur J Clin Pharmacol; 1991; 41(3):259-61. PubMed ID: 1748144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of Cushing's disease with o,p'-DDD followed by pituitary irradiation in a 19-year-old male patient.
    Dickerman Z; Kaufman H; Laron Z
    Isr J Med Sci; 1979 May; 15(5):455-9. PubMed ID: 447515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of Cushing's syndrome and adrenal cancer with O,p-DDD].
    Kinouchi T; Shimizu N; Ibayashi H; Demura H; Oshima H
    Horumon To Rinsho; 1982 Aug; 30(8):841-51. PubMed ID: 7139984
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effects of o,p'-DDD on human adrenal steroid synthesis].
    Ojima M; Saito M; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1984 Jul; 60(7):852-71. PubMed ID: 6094274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple recurrence of Cushing's syndrome after bilateral adrenalectomy and pituitary gland surgery. Cure with o,p'-DDD].
    Bigler U; Müller J
    Schweiz Med Wochenschr; 1978 Jan; 108(2):67-72. PubMed ID: 622536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The long-term therapy of hypothalamic-hypophyseal Cushing's syndrome with mitotane (o,p'-DDD)].
    Knappe G; Gerl H; Ventz M; Rohde W
    Dtsch Med Wochenschr; 1997 Jul; 122(28-29):882-6. PubMed ID: 9264918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Cushing's disease with op' DDD].
    Golik A; Rosenberg T; Gilboa Y
    Harefuah; 1975 Dec; 89(12):563-4. PubMed ID: 1218835
    [No Abstract]   [Full Text] [Related]  

  • 12. The protracted effect of o,p'-DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo.
    Leiba S; Weinstein R; Shindel B; Lapidot M; Stern E; Levavi H; Rusecki Y; Abramovici A
    Ann Endocrinol (Paris); 1989; 50(1):49-53. PubMed ID: 2729882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. o,p'-DDD (mitotane) treatment for Cushing's syndrome: adrenal drug concentration and inhibition in vitro of steroid synthesis.
    Touitou Y; Moolenaar AJ; Bogdan A; Auzéby A; Luton JP
    Eur J Clin Pharmacol; 1985; 29(4):483-7. PubMed ID: 4092727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [12 years of medical treatment of Cushing's disease. Long-term use of Op, DDD in 46 cases].
    Bricaire H; Luton JP
    Nouv Presse Med; 1976 Feb; 5(6):325-9. PubMed ID: 1264700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of mitotane (o,p'-DDD) in adrenal cortex hyperfunction].
    Kasperlik-Załuska A; Migdalska B
    Endokrynol Pol; 1982; 33(1-3):99-104. PubMed ID: 7183447
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical usefulness of pharmacological treatment of Cushing's syndrome].
    Saito J; Nishikawa T
    Nihon Rinsho; 1994 Mar; 52(3):793-6. PubMed ID: 8164384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Cushing's syndrome with chloditane].
    Komissarenko IV
    Klin Med (Mosk); 1976 Sep; 54(9):122-7. PubMed ID: 1003908
    [No Abstract]   [Full Text] [Related]  

  • 18. o,p-DDD in the treatment of Cushing's disease.
    Nash AS; Bogan JA
    Vet Rec; 1978 May; 102(21):470. PubMed ID: 664205
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recovery or remission of Cushing's disease following long term administration of OP'DDD in seventeen patients (author's transl)].
    Luton JP; Remy JM; Valcke JC; Laudat P; Bricaire H
    Ann Endocrinol (Paris); 1973; 34(4):351-76. PubMed ID: 4360563
    [No Abstract]   [Full Text] [Related]  

  • 20. o,p'-DDD (mitotane) treatment of canine pituitary-dependent hyperadrenocorticism.
    Peterson ME
    J Am Vet Med Assoc; 1983 Mar; 182(5):527-8. PubMed ID: 6300010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.